UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044899
Receipt number R000051278
Scientific Title A prospective observational study of the effects of swallowing function, feeding status, and gargling on salivary bacterial counts in patients undergoing oral cancer surgery
Date of disclosure of the study information 2021/07/21
Last modified on 2022/07/20 17:18:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study of the effects of swallowing function, feeding status, and gargling on salivary bacterial counts in patients undergoing oral cancer surgery

Acronym

Relationship between swallowing function, feeding status, gargling and salivary bacterial count in patients undergoing oral cancer surgery

Scientific Title

A prospective observational study of the effects of swallowing function, feeding status, and gargling on salivary bacterial counts in patients undergoing oral cancer surgery

Scientific Title:Acronym

Relationship between swallowing function, feeding status, gargling and salivary bacterial count in patients undergoing oral cancer surgery

Region

Japan


Condition

Condition

Oral cancer

Classification by specialty

Oral surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the risk factors for the increase in the number of bacteria by measuring the number of bacteria in saliva before and after oral cancer surgery

Basic objectives2

Others

Basic objectives -Others

The change of number of bacterial count before and after surgery

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of bacteria in saliva, presence or absence of swallowing dysfunction and feeding status, before and after surgery

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who undergo oral cancer surgery under general anesthesia at Nagasaki University Hospital from the date of permission from the hospital director to July 31, 2022 (including recurrence).

Key exclusion criteria

1.Patients managed under intubation after surgery (oral or nasal intubation, tracheostomy)
2.Patients without wounds in the oral cavity ( only Neck dissection surgery)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Sakiko
Middle name
Last name Soutome

Organization

Nagasaki University Graduate School of
Biomedical Sciences

Division name

Department of Oral Health

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki, Japan

TEL

095-819-7698

Email

sakiko@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Sakiko
Middle name
Last name Soutome

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Oral Health

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki, Japan

TEL

095-8197-698

Homepage URL


Email

sakiko@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board (IRB) of Nagasaki University Hospital

Address

1-7-1 Sakamoto, Nagasaki, Japan

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2021 Year 07 Month 20 Day

Date of IRB

2021 Year 07 Month 20 Day

Anticipated trial start date

2021 Year 07 Month 21 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Measurement of the number of bacteria in saliva


Management information

Registered date

2021 Year 07 Month 19 Day

Last modified on

2022 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051278


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name